alpha-L-Fucp-(1->2)-beta-D-Galp6S-(1->4)-beta-D-Glcp

Term ID

CHEBI:86138

Synonyms

6-deoxy-alpha-L-galactopyranosyl-(1->2)-6-O-sulfo-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranose
alpha-L-Fuc-(1->2)-beta-D-Gal6S-(1->4)-beta-D-Glc
alpha-L-fucopyranosyl-(1->2)-6-O-sulfo-beta-D-galactopyranosyl-(1->4)-D-beta-glucopyranose
alpha-L-fucosyl-(1->2)-6-O-sulfo-beta-D-galactosyl-(1->4)-beta-D-glucose
Fuca1-2(6S)Galb1-4Glcb
Fucalpha1-2[6OSO3]Galbeta1-4Glcbeta
O-6-deoxy-alpha-L-galactopyranosyl-(1->2)-O-6-O-sulfo-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranose

Definition

alpha-L-Fucp-(1->2)-beta-D-Galp6S-(1->4)-D-Glcp in which the anomeric configuration of the glucose residue at the reducing end is beta.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: alpha-L-Fucp-(1->2)-beta-D-Galp6S-(1->4)-D-Glcp

alpha-L-Fucp-(1->2)-beta-D-Galp6S-(1->4)-D-Glcp Show first 5 Terms

Phenotype

Phenotype resulting from alpha-L-Fucp-(1->2)-beta-D-Galp6S-(1->4)-beta-D-Glcp

Phenotype where environments contain alpha-L-Fucp-(1->2)-beta-D-Galp6S-(1->4)-beta-D-Glcp

Phenotype modified by environments containing alpha-L-Fucp-(1->2)-beta-D-Galp6S-(1->4)-beta-D-Glcp

Human Disease Model